Patent assignee · AU · COMPANY

Antisense Therapeutics Ltd

18Patents
15Active
18Granted
44Portfolio score

Filing activity: Feb 11, 2004 → May 6, 2019 · 4 expiring within 5 years

Most-cited patents

PatentTitleAreaCited byStatus
US8623836B2 Modulation of growth hormone receptor expression and insulin-like growth factor expression Emerging Cross-Sectional Technologies 4 Active
US8759314B2 Methods for treating multiple sclerosis using antisense oligonucleotides Chemistry; Metallurgy 2 Active
US9084770B2 Modulation of insulin like growth factor I receptor expression in cancer Chemistry; Metallurgy 2 Active
US9717778B2 Combination therapy Human Necessities 2 Active
US8299039B2 Modulation of growth hormone receptor expression and insulin-like growth factor expression Emerging Cross-Sectional Technologies 2 Expired
US8415314B2 Methods for treating multiple sclerosis using antisense oligonucleotides Chemistry; Metallurgy 2 Active
US8765700B2 Topical administrations of antisense compounds to VLA-4 for the treatment of respiratory conditions Chemistry; Metallurgy 1 Active
US7468356B2 Modulation of insulin like growth factor I receptor expression Emerging Cross-Sectional Technologies 1 Expired
US11041156B2 Mobilizing leukemia cells Chemistry; Metallurgy 0 Active
US8217017B2 Modulation of insulin like growth factor I receptor expression Emerging Cross-Sectional Technologies 0 Active
US11976281B2 Therapeutic uses and methods Chemistry; Metallurgy 0 Active
US9821034B2 Combination therapy Human Necessities 0 Active
US7846906B2 Modulation of growth hormone receptor expression and insulin-like growth factor expression Emerging Cross-Sectional Technologies 0 Expired
US8637484B2 Modulation of growth hormone receptor expression and insulin-like growth factor expression Emerging Cross-Sectional Technologies 0 Active
US9988635B2 Modulation of growth hormone receptor expression and insulin-like growth factor expression Emerging Cross-Sectional Technologies 0 Active
US9885048B2 Method for reducing circulating leukocytes in a human subject Chemistry; Metallurgy 0 Active
US11891606B2 Methods for treating multiple sclerosis using antisense oligonucleotides Chemistry; Metallurgy 0 Active
US9371530B2 Modulation of growth hormone receptor expression and insulin-like growth factor expression Emerging Cross-Sectional Technologies 0 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.